| Entry |
|
|---|
| Name |
Levonordefrin (USP);
Corbadrine (INN);
Neo-cobefrin (TN)
|
|---|
| Formula |
C9H13NO3
|
|---|
| Exact mass |
183.0895
|
|---|
| Mol weight |
183.2044
|
|---|
| Structure |
     |
|---|
| Activity |
Adrenergic [vasoconstrictor], Antihypertensive
|
|---|
| Remark |
|
|---|
| Comment |
Metabolite of Methyldopa [DR: D08205]
|
|---|
| Target |
|
|---|
| Pathway |
hsa04080 Neuroactive ligand-receptor interaction | |
|
|---|
| Interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
alpha2-adrenergic receptor [HSA:150 151 152] [KO:K04138 K04139 K04140]
Levonordefrin
D02388 Levonordefrin (USP); Corbadrine (INN)
 |
|---|
| Other DBs |
CAS: 829-74-3 PubChem: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 13
1 C8y C 25.6200 -15.8200
2 C8x C 25.6200 -17.2200
3 C8x C 24.4300 -15.1200
4 C1c C 26.8100 -15.1200
5 C8x C 24.4300 -17.9200
6 C8y C 23.1700 -15.8200
7 C1c C 28.0000 -15.7500
8 O1a O 26.8100 -13.7200
9 C8y C 23.1700 -17.2200
10 C1a C 29.2600 -15.0500
11 O1a O 21.9800 -17.9200
12 N1a N 28.0000 -17.1500
13 O1a O 21.9800 -15.1200
BOND 13
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 2
6 4 7 1
7 4 8 1 #Up
8 5 9 2
9 7 10 1
10 9 11 1
11 6 9 1
12 7 12 1 #Down
13 6 13 1
|
|---|
